|
|||||||||||||||
Table III. Average FDA review time and average total elapsed time, from filing to approval, for all original premarket approval (PMA) applications and panel-track PMA supplements (excluding withdrawals), FY01–FY04. Source: FDA Office of Device Evaluation. |